Sale!

MED23 Gene Mental Retardation Autosomal Recessive Type 18 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The MED23 Gene Mental Retardation Autosomal Recessive Type 18 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the MED23 gene responsible for this rare neurological condition. Using next-generation sequencing technology, this test provides comprehensive analysis of the MED23 gene to detect pathogenic variants associated with autosomal recessive mental retardation type 18. The test is particularly valuable for individuals presenting with developmental delays, intellectual disabilities, and neurological symptoms. For only $500 USD, patients gain access to precise genetic information that can guide treatment decisions, inform family planning, and provide clarity about inherited conditions. This advanced testing method offers superior accuracy compared to traditional genetic screening approaches.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

MED23 Gene Mental Retardation Autosomal Recessive Type 18 NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The MED23 Gene Mental Retardation Autosomal Recessive Type 18 NGS Genetic DNA Test represents a breakthrough in diagnostic precision for individuals and families affected by inherited neurological conditions. This advanced genetic screening utilizes next-generation sequencing (NGS) technology to provide unparalleled accuracy in detecting mutations within the MED23 gene, which plays a crucial role in neurological development and cognitive function.

What Does This Test Measure?

This specialized genetic test specifically targets and analyzes the MED23 gene for pathogenic variants associated with autosomal recessive mental retardation type 18. The test examines:

  • Complete sequencing of the MED23 gene coding regions
  • Detection of single nucleotide variants (SNVs)
  • Identification of small insertions and deletions (indels)
  • Analysis of copy number variations (CNVs)
  • Assessment of splice site mutations

The MED23 gene encodes a critical component of the mediator complex, which regulates transcription initiation and is essential for proper neural development and cognitive function.

Who Should Consider This Test?

This genetic test is particularly recommended for individuals presenting with:

  • Unexplained developmental delays in childhood
  • Intellectual disability of unknown origin
  • Family history of autosomal recessive neurological disorders
  • Consanguineous parentage with neurological symptoms
  • Multiple affected siblings with similar neurological presentations
  • Progressive cognitive impairment without clear diagnosis
  • Neurological symptoms consistent with MED23-related disorders

Clinical Benefits of MED23 Genetic Testing

Undergoing MED23 gene testing provides numerous advantages for patients and families:

  • Accurate Diagnosis: Provides definitive identification of MED23 gene mutations
  • Family Planning Guidance: Enables informed reproductive decisions
  • Early Intervention: Facilitates timely therapeutic interventions
  • Genetic Counseling: Supports comprehensive family risk assessment
  • Treatment Planning: Informs personalized management strategies
  • Prognostic Information: Helps understand disease progression patterns

Understanding Your Test Results

Your MED23 gene test results will be carefully interpreted by our team of genetic specialists:

  • Positive Result: Indicates the presence of pathogenic MED23 gene mutations consistent with autosomal recessive mental retardation type 18
  • Negative Result: Suggests no detectable MED23 mutations, though other genetic causes should be considered
  • Variant of Uncertain Significance (VUS): Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if an individual carries one copy of a mutated MED23 gene

All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps.

Test Pricing and Details

Test Component Details
Test Name MED23 Gene Mental Retardation Autosomal Recessive Type 18 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Specialty Neurologist
Department Genetics
Method NGS Technology
Disease Type Neurological Disorders

Pre-Test Requirements

Before undergoing MED23 genetic testing, patients should provide:

  • Complete clinical history of neurological symptoms
  • Genetic counseling session to create detailed family pedigree
  • Documentation of affected family members
  • Informed consent for genetic testing

Nationwide Testing Availability

We proudly offer MED23 genetic testing services across the United States with convenient locations in major cities including New York, Los Angeles, Chicago, Houston, Phoenix, and many others. Our state-of-the-art genetic laboratories ensure consistent, high-quality testing regardless of location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about neurological symptoms affect your family’s future. Our MED23 Gene Mental Retardation Autosomal Recessive Type 18 NGS Genetic DNA Test provides the answers you need for informed healthcare decisions. With our discounted price of only $500 USD, advanced genetic testing is more accessible than ever.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your MED23 gene test. Our genetic specialists are ready to guide you through every step of the testing process and help you understand your results with compassion and expertise.